![Trajectories of serum α-fetoprotein and intermediate-stage hepatocellular carcinoma outcomes after transarterial chemoembolization: A longitudinal, retrospective, multicentre, cohort study - eClinicalMedicine Trajectories of serum α-fetoprotein and intermediate-stage hepatocellular carcinoma outcomes after transarterial chemoembolization: A longitudinal, retrospective, multicentre, cohort study - eClinicalMedicine](https://www.thelancet.com/cms/asset/20cdeb92-3302-416d-a053-937702b7b85a/gr1.jpg)
Trajectories of serum α-fetoprotein and intermediate-stage hepatocellular carcinoma outcomes after transarterial chemoembolization: A longitudinal, retrospective, multicentre, cohort study - eClinicalMedicine
![PDF) Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies PDF) Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies](https://www.researchgate.net/profile/Esaki-Muthu-Shankar/publication/51431045/figure/tbl1/AS:601654453862407@1520457008233/Alpha-fetoprotein-positivity-profile-in-hepatocellular-carcinoma-cases-N-142_Q320.jpg)
PDF) Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies
![The Innovation | Medicine on Twitter: "Commonly used Tumor Markers A tumor marker is a biomarker found in blood, urine, or body tissues that can be elevated by the presence of one The Innovation | Medicine on Twitter: "Commonly used Tumor Markers A tumor marker is a biomarker found in blood, urine, or body tissues that can be elevated by the presence of one](https://pbs.twimg.com/media/FdDwvxeXgAMJJDi.jpg)
The Innovation | Medicine on Twitter: "Commonly used Tumor Markers A tumor marker is a biomarker found in blood, urine, or body tissues that can be elevated by the presence of one
![Alpha-fetoprotein for Gastric Cancer Staging: An Essential or Redundant Tumor Marker? | Anticancer Research Alpha-fetoprotein for Gastric Cancer Staging: An Essential or Redundant Tumor Marker? | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/41/5/2711/F1.large.jpg)
Alpha-fetoprotein for Gastric Cancer Staging: An Essential or Redundant Tumor Marker? | Anticancer Research
![Cancers | Free Full-Text | Baseline Alpha-Fetoprotein, Alpha-Fetoprotein-L3, and Des-Gamma-Carboxy Prothrombin Biomarker Status in Bridge to Liver Transplant Outcomes for Hepatocellular Carcinoma Cancers | Free Full-Text | Baseline Alpha-Fetoprotein, Alpha-Fetoprotein-L3, and Des-Gamma-Carboxy Prothrombin Biomarker Status in Bridge to Liver Transplant Outcomes for Hepatocellular Carcinoma](https://www.mdpi.com/cancers/cancers-13-04765/article_deploy/html/images/cancers-13-04765-g001.png)
Cancers | Free Full-Text | Baseline Alpha-Fetoprotein, Alpha-Fetoprotein-L3, and Des-Gamma-Carboxy Prothrombin Biomarker Status in Bridge to Liver Transplant Outcomes for Hepatocellular Carcinoma
![AFP promotes HCC progression by suppressing the HuR-mediated Fas/FADD apoptotic pathway | Cell Death & Disease AFP promotes HCC progression by suppressing the HuR-mediated Fas/FADD apoptotic pathway | Cell Death & Disease](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41419-020-03030-7/MediaObjects/41419_2020_3030_Fig1_HTML.png)
AFP promotes HCC progression by suppressing the HuR-mediated Fas/FADD apoptotic pathway | Cell Death & Disease
![Real impact of tumor marker AFP and PIVKA-II in detecting very small hepatocellular carcinoma (≤ 2 cm, Barcelona stage 0) - assessment with large number of cases Real impact of tumor marker AFP and PIVKA-II in detecting very small hepatocellular carcinoma (≤ 2 cm, Barcelona stage 0) - assessment with large number of cases](https://f6publishing.blob.core.windows.net/850a7c84-f748-4a79-8158-3d67696ca7ca/WJH-12-1046-g001.png)
Real impact of tumor marker AFP and PIVKA-II in detecting very small hepatocellular carcinoma (≤ 2 cm, Barcelona stage 0) - assessment with large number of cases
![Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics](https://pubs.rsna.org/cms/10.1148/rg.2021210005/asset/images/medium/rg.2021210005.va.gif)